RecruitingNot ApplicableNCT07832279

1-Week Versus 3-Week PBI

1-Week Versus 3-Week Partial Breast Irradiation Using Intensity-Modulated Radiation Therapy (IMRT) Following Breast-Conserving Surgery in Clinically Low-Risk Breast Cancer: a Phase III, Randomized Trial

Sponsor

Fudan University

Enrollment

818 participants

Start Date

Oct 1, 2026

Study Type

INTERVENTIONAL

Conditions

Early Stage Breast Cancer

Summary

This non-inferiority, phase 3 clinical trial evaluates the cosmetic non-inferiority of a one-week regimen (26 Gy/5 Fx) versus a three-week regimen (40 Gy/15 Fx) using intensity-modulated radiation therapy (IMRT) for partial breast irradiation (PBI) in low-risk breast cancer patients post-breast-conserving surgery.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying 1-week PBI and 3-week PBI for people with early stage breast cancer. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.